Choose a blog

GSK to dump Goody's, Alli, other consumer products

GlaxoSmithKline plans to sell 19 of its consumer-health brands, including the controversial Alli weight-loss drug and Goody's, the headache powder invented in Winston-Salem.

CEO Andrew Witty announced in February that the pharmaceutical giant planned to sell some "non-core" brands to raise money and focus attention on faster-growing products.

Today, the company released a list of products it plans to divest, including Beano gas relief, Debrox ear wax cleanser, Nytol sleep aid and others.

Combined, the products contribute more than $800 million a year in revenue for GSK, the British corporation that has its North American headquarters in Research Triangle Park.

Cars View All
Find a Car
Go
Jobs View All
Find a Job
Go
Homes View All
Find a Home
Go

Want to post a comment?

In order to join the conversation, you must be a member of newsobserver.com. Click here to register or to log in.
Advertisements